Literature DB >> 9384297

Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology.

E Grimprel1, E Njamkepo, P Bégué, N Guiso.   

Abstract

The contribution of maternal pertussis serology comparing prepartum serum to serum collected during the infant's disease to the diagnosis of pertussis in infants was evaluated for 28 pairs of young infants with pertussis syndrome and their mothers and was compared to those of culture and PCR. Infants had a nasopharyngeal aspiration tested by PCR, and acute and convalescent sera were collected during their disease. Mothers had a first acute serum collected concomitantly with the infant's acute serum, and both acute sera were compared to a prepartum serum. Sera were analyzed by immunoblotting for the detection of anti-pertussis toxin (PT) antibodies. Serological evidence of pertussis in infants was assessed as either an increase in anti-PT antibody levels between the mother's prepartum and acute sera or the presence of antibodies in the infant's acute serum and their absence in both the mother's acute and prepartum sera. Culture and PCR sensitivity were 43 and 89%, respectively. Most infants (18 of 24) had no pertussis antibody detectable in their acute sera, confirming a delayed immune response at this age. A comparison of infant's and mother's serology, using prepartum serum, rapidly confirmed the diagnosis in 57% of the cases. Although less sensitive than PCR, this serological method should be used for a rapid diagnosis of pertussis in young infants when culture and PCR are either not available or negative.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384297      PMCID: PMC170648          DOI: 10.1128/cdli.4.6.723-726.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  12 in total

1.  Serologic evidence of subclinical pertussis in immunized children.

Authors:  S S Long; H W Lischner; A Deforest; J L Clark
Journal:  Pediatr Infect Dis J       Date:  1990-10       Impact factor: 2.129

2.  A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population.

Authors:  A van der Zee; C Agterberg; M Peeters; F Mooi; J Schellekens
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

3.  Specific identification of Bordetella pertussis by the polymerase chain reaction.

Authors:  S Houard; C Hackel; A Herzog; A Bollen
Journal:  Res Microbiol       Date:  1989-09       Impact factor: 3.992

4.  The return of pertussis.

Authors:  J W Bass; S R Stephenson
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

5.  Laboratory diagnosis of pertussis: the state of the art.

Authors:  I M Onorato; S G Wassilak
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

6.  Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections.

Authors:  B D Meade; A Bollen
Journal:  J Med Microbiol       Date:  1994-07       Impact factor: 2.472

7.  Intrafamilial spread of pertussis.

Authors:  J Mertsola; O Ruuskanen; E Eerola; M K Viljanen
Journal:  J Pediatr       Date:  1983-09       Impact factor: 4.406

8.  Outcomes of Bordetella pertussis infection in different age groups of an immunized population.

Authors:  Q He; M K Viljanen; S Nikkari; R Lyytikäinen; J Mertsola
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

9.  Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection.

Authors:  E Grimprel; P Bégué; I Anjak; F Betsou; N Guiso
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis.

Authors:  Q He; J Mertsola; J P Himanen; O Ruuskanen; M K Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

View more
  2 in total

1.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants.

Authors:  Aaron M Wendelboe; Michael G Hudgens; Charles Poole; Annelies Van Rie
Journal:  Emerg Themes Epidemiol       Date:  2007-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.